Kreutmair, Stefanie http://orcid.org/0000-0001-8466-6675
Pfeifer, Dietmar
Waterhouse, Miguel
Takács, Ferenc
Graessel, Linda
Döhner, Konstanze
Duyster, Justus
Illert, Anna Lena
Frey, Anna-Verena
Schmitt, Michael
Lübbert, Michael
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (FOR2674 A05)
Deutschen Konsortium für Translationale Krebsforschung (L660)
Universitätsklinikum Freiburg
Article History
Received: 6 August 2021
Accepted: 1 April 2022
First Online: 27 April 2022
Declarations
:
: The authors have no relevant financial or non-financial interests to disclose.
: The study was initiated and sponsored by GlaxoSmithKline Biologicals SA (NCT01051063). The study was approved by the Local Ethics Committee of the University Hospital Freiburg, and written informed consent was obtained from each patient prior to study. The study was conducted in accordance with Good Clinical Practice guidelines and the Declaration of Helsinki.